The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
- Conditions
- Bradycardia
- Interventions
- Device: Leadless Pacemaker
- Registration Number
- NCT02030418
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
Prospective, non-randomized, single-arm, international multicenter, clinical safety and effectiveness of a leadless pacemaker system in patients who are indicated for a VVIR pacemaker.
Following completion of enrollments in the IDE, patients will continue to be enrolled in the continued access phase of the study under the same protocol.
- Detailed Description
The purpose of this study is to evaluate the safety and effectiveness of the leadless pacemaker system in treating patients with a slow heart rate or irregular heartbeats. The Nanostim leadless pacemaker provides bradycardia pacing as a pulse generator with built-in battery and electrodes, for permanent implantation in the right ventricle. As a leadless pacemaker, it does not need a connector, pacing lead, or pulse generator pocket, but it has the same operating principles as a conventional pacemaker.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 526
-
Subject must have one of the clinical indications before device implant in adherence with Medicare, ACC/AHA/HRS/ESC single chamber pacing guidelines including:
- Chronic and/or permanent atrial fibrillation with 2 or 3Β° AV or bifascicular bundle branch block (BBB block), including slow ventricular rates (with or without medication) associated with atrial fibrillation; or
- Normal sinus rhythm with 2 or 3Β° AV or BBB block and a low level of physical activity or short expected lifespan (but at least one year); or
- Sinus bradycardia with infrequent pauses or unexplained syncope with EP findings; and
-
Subject β₯18 years of age; and
-
Subject has life expectancy of at least one year; and
-
Subject is not enrolled in another clinical investigation; and
-
Subject is willing to comply with clinical investigation procedures and agrees to return for all required follow-up visits, tests, and exams; and
-
Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the IRB; and
-
Subject is not pregnant and does not plan to get pregnant during the course of the study.
- Subject has pacemaker syndrome, has retrograde VA conduction or suffers a drop in arterial blood pressure with the onset of ventricular pacing; or
- Subject is allergic or hypersensitive to <1 mg of dexamethasone sodium phosphate; or
- Subject has a mechanical tricuspid valve prosthesis; or
- Subject has a pre-existing endocardial pacing or defibrillation leads; or
- Subject has current implantation of either conventional or subcutaneous implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT); or
- Subject has an implanted vena cava filter; or
- Subject has evidence of thrombosis in one of the veins used for access during the procedure; or
- Subject has an implanted leadless cardiac pacemaker; or
- Subject had recent cardiovascular or peripheral vascular surgery within 30 days of enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Leadless Pacemaker Leadless Pacemaker VVIR pacing
- Primary Outcome Measures
Name Time Method Pacing thresholds and R-wave amplitudes within the therapeutic range 6 months Complication-Free Rate 6 months
- Secondary Outcome Measures
Name Time Method appropriate and proportional rate response during graded exercise testing 3-6 months
Trial Locations
- Locations (59)
El Camino Hospital
πΊπΈMountain View, California, United States
Premier Cardiology, Inc
πΊπΈNewport Beach, California, United States
University of Chicago
πΊπΈChicago, Illinois, United States
Huntington Memorial Hospital
πΊπΈPasadena, California, United States
WellSpan Health
πΊπΈYork, Pennsylvania, United States
Vancouver General Hospital (U of BC)
π¨π¦Vancouver, British Columbia, Canada
Princess Alexandra Hospital
π¦πΊWoolloongabba, Queensland, Australia
Tufts Medical Center
πΊπΈBoston, Massachusetts, United States
Massachusetts General Hospital
πΊπΈBoston, Massachusetts, United States
University Hospitals of Cleveland
πΊπΈCleveland, Ohio, United States
Integris Baptist Medical Center
πΊπΈOklahoma City, Oklahoma, United States
St. John Hospital and Medical Center
πΊπΈDetroit, Michigan, United States
Duke University Medical Center
πΊπΈDurham, North Carolina, United States
The Cleveland Clinic Foundation
πΊπΈCleveland, Ohio, United States
Memorial Hermann Hospital
πΊπΈHouston, Texas, United States
Heart Center Research, LLC.
πΊπΈHuntsville, Alabama, United States
University Hospital - Univ. of Alabama at Birmingham
πΊπΈBirmingham, Alabama, United States
USC University Hospital
πΊπΈLos Angeles, California, United States
Scripps Health
πΊπΈLa Jolla, California, United States
Sequoia Hospital
πΊπΈRedwood City, California, United States
Naples Community Hospital
πΊπΈNaples, Florida, United States
South Denver Cardiology Associates PC
πΊπΈLittleton, Colorado, United States
Piedmont Athens Regional Medical Center
πΊπΈAthens, Georgia, United States
Parkview Research Center
πΊπΈFort Wayne, Indiana, United States
Redmond Regional Medical Center
πΊπΈRome, Georgia, United States
St. Elizabeth Medical Center
πΊπΈEdgewood, Kentucky, United States
Advocate Christ Medical Center
πΊπΈOak Lawn, Illinois, United States
Kansas University Medical Center
πΊπΈKansas City, Kansas, United States
Lahey Clinic Medical Center
πΊπΈBurlington, Massachusetts, United States
Sparrow Research
πΊπΈLansing, Michigan, United States
Munson Medical Center
πΊπΈTraverse, Michigan, United States
Michigan Heart
πΊπΈYpsilanti, Michigan, United States
Fairview Southdale Hospital
πΊπΈEdina, Minnesota, United States
Mercy Hospital St. Louis
πΊπΈSaint Louis, Missouri, United States
Jersey Shore University Medical Center
πΊπΈNeptune, New Jersey, United States
New York Presbyterian Hospital/Cornell University
πΊπΈNew York, New York, United States
Cardiac Arrhythmia and Pacemaker Center
πΊπΈRoslyn, New York, United States
Cone Health Medical Group HeartCare
πΊπΈGreensboro, North Carolina, United States
University of Pittsburgh Medical Center
πΊπΈPittsburgh, Pennsylvania, United States
Methodist University Hospital
πΊπΈMemphis, Tennessee, United States
South Texas Cardiovascular Consultants
πΊπΈSan Antonio, Texas, United States
Clinical Tex Research, LLC
πΊπΈAmarillo, Texas, United States
Intermountain Heart Rhythm Specialists
πΊπΈMurray, Utah, United States
Inova Fairfax Hospital
πΊπΈFalls Church, Virginia, United States
The Prince Charles Hospital
π¦πΊChermside, Queensland, Australia
Royal Adelaide Hospital
π¦πΊAdelaide, South Australia, Australia
Foothills Medical Centre
π¨π¦Calgary, Alberta, Canada
Kinsgston General Hospital
π¨π¦Kingston, Ontario, Canada
Institut de Cardiologie de Quebec (Hospital Laval)
π¨π¦Quebec, Canada
Institut de Cardiologie de Montreal (Montreal Heart Inst.)
π¨π¦Montreal, Quebec, Canada
Southlake Regional Health Centre
π¨π¦Newmarket, Ontario, Canada
Mount Sinai Hospital
πΊπΈNew York, New York, United States
Mercy Medical Group - Cardiology
πΊπΈSacramento, California, United States
AdventHealth Orlando
πΊπΈOrlando, Florida, United States
Orlando Health
πΊπΈOrlando, Florida, United States
Baptist Health Lexington
πΊπΈLexington, Kentucky, United States
Ochsner Medical Center
πΊπΈNew Orleans, Louisiana, United States
Mayo Clinic
πΊπΈRochester, Minnesota, United States
Aurora Medical Group
πΊπΈMilwaukee, Wisconsin, United States